Regeneron Pharmaceuticals REGN
NASDAQ REGN
$831.95 -11.52 (-1.37%)
As of: Sep 4, 2026 · 2:35 PM EDT

Regeneron Pharmaceuticals (REGN) Gross Margin (QoQ) (2009 - 2026)

Analysis

Regeneron Pharmaceuticals (REGN) Gross Margin (QoQ) (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.77 Bn 130.92 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.51 Bn 77.52 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.20 Bn 53.06 Bn 52.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn -
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn
8 Royalty Pharma 28.40 Bn 27.56 Bn -
9 Insmed 27.44 Bn 26.28 Bn 358.27 Mn
10 Incyte 25.59 Bn 21.05 Bn 1.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 195.00
Mar 31, 2026 -215.00
Dec 31, 2025 -72.00
Sep 30, 2025 1.00
Jun 30, 2025 127.00
Mar 31, 2025 -14.00
Dec 31, 2024 -157.00
Sep 30, 2024 22.00
Jun 30, 2024 38.00
Mar 31, 2024 -11.00
Dec 31, 2023 -85.00
Sep 30, 2023 5.00
Jun 30, 2023 115.00
Mar 31, 2023 27,012.00
Dec 31, 2022 -27,199.00
Sep 30, 2022 -79.00
Jun 30, 2022 177.00
Mar 31, 2022 940.00
Dec 31, 2021 -948.00
Sep 30, 2021 358.00